Arbutus Biopharma Corporation
Long
Updated

ABUS Swing

155
ABUS have a high evaluation above 5.5$ while its currently trading at 3.6 $ expecting profiting from MRNA and PFE patent royalties , currently touching rising trend line and it could be a good entry to start accumulating
Trade closed: target reached
take profit at 4 and 4.5

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.